Lincoln Park Bancorp (LPBC) 6.4800 $LPBC
Lincoln Park Bancorp Announces Earnings For The Quarter Ended June 30, 2014
PR Newswire - Fri Aug 08, 4:00PM CDT
Lincoln Park Bancorp (OTC Bulletin Board: LPBC) (the "Company"
, the holding company of Lincoln Park Savings Bank, announced net income of $327,000, or $.19 per share, for the quarter ended June 30, 2014, compared to net income of $216,000 or $.12 per share, for the quarter ended June 30, 2013. The increase in net income of $111,000 was primarily due to an increase in net interest income after provision for loan losses, partially offset by a decrease in non-interest income, an increase in non-interest expenses, and an increase in income tax expense.
Poll Shows Americans Deeply Concerned about Online Privacy, Mistrust Social Media
PR Newswire - Thu Jul 31, 7:30AM CDT
Almost three-quarters of Americans worry about the quantity of personal information available online and more than half feel they cannot trust social media sites like Facebook and Twitter to keep their contact information, buying habits and political beliefs confidential, according to new poll data released today at http://www.onlineprivacydata.org.
Biodel signs USD15m equity agreement with Lincoln Park Capital
M2 - Mon Jul 28, 6:24AM CDT
Biopharmaceutical company Biodel (NasdaqCM:BIOD) revealed on Monday the execution of a USD15m stock purchase agreement with Lincoln Park Capital Fund (LPC), a Chicago-based institutional investor.
Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital
Marketwire - Mon Jul 28, 5:00AM CDT
Biodel Inc. (NASDAQ: BIOD) today announced that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC" , a Chicago-based institutional investor. Under the terms of the purchase agreement, Biodel will have the right to sell to LPC, and LPC will be obligated to purchase, up to $15 million in shares of Biodel's common stock, subject to the limitations and conditions set forth in the agreement. Biodel intends to use any proceeds that it receives from the sale of shares under the purchase agreement for general corporate purposes and working capital requirements.
Miller-Valentine Group Proudly Announces the 25th Anniversary of Lincoln Park Manor in Kettering, Ohio
PRWeb - Wed Jul 16, 1:36PM CDT
This year marks the 25th anniversary of Lincoln Park Manor as their first patient was admitted on July 17, 1989. Lincoln Park Manor is owned by Miller-Valentine Group, a trusted name in Dayton and many communities. Together they have built a reputation of integrity and best business practices. Every day the staff at Lincoln Park Manor lives up to these expectations and strives to exceed them. Their dedication has been acknowledged by achieving a deficiency free health survey for the last two consecutive annual surveys conducted by the Ohio Department of Health and a 5 Star Rating with Medicare.
Advanced Cell Technology Secures $30 Million Equity Facility from Lincoln Park Capital
Business Wire - Thu Jul 03, 8:05AM CDT
Advanced Cell Technology, Inc. ("ACT" (OTCBB:ACTC), a leader in the field of regenerative medicine, today announced that it has entered into a $30 million common stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC" .
Amarantus BioScience Holdings, Inc. "Transformational Funding Positions Amarantus Heading into 2014 Milestones"
ACCESSWIRE - Mon Mar 10, 12:46PM CDT
New York, NY / ACCESSWIRE / March 10, 2014 / Amarantus BioScience Holdings, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman's Blog, written by the Company's CEO, Mr. Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC
GlobeNewswire - Mon Mar 10, 5:00AM CDT
Amarantus Bioscience Holdings, Inc. (OTC:AMBS) (Amarantus or the Company), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, announced today that it has closed on its previously announced Warrant Solicitation, which the Company elected to increase in size from $3.0M to $3.6M due to oversubscriptions. Concurrently, the Company entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC" , a Chicago-based institutional investor. LPC initially purchased 4.0 million shares of Amarantus' common stock at $0.10 per share for $400,000 and has committed to invest, at the sole option of Amarantus, up to an additional $19.6M of equity capital over the term of the purchase agreement. The total gross proceeds to the Company from these two transactions upon closing is $4M.
Experience the Difference at Lincoln Park Manor; Recognized for Deficiency-Free Health Survey
PRWeb - Sat Mar 08, 11:45AM CST
Russ Holtz, Executive Director of Lincoln Mark Manor, is proud of the 2014 survey results and is honored with the overall 5-Star rating from Medicare. Holtz states, "We have maintained this outstanding accomplishment for the second consecutive year. We understand the importance of having an amazing, caring team of staff members who continue to play a key role towards this distinction year after year."
PourMyBeer™ Revolutionizes Beer Service in Chicago with Introduction of Self-Serve System
PRWeb - Fri Mar 07, 5:05AM CST
Craft beer is at an all-time high and customer demand for beer means the need to serve them more quickly, efficiently and responsibly is greater than ever. Enter the PourMyBeer™ system. It conveniently allows customers to purchase and pour their own beer, with staff interaction and oversight of course. It also allows customers to pay only for what they drink, instead of a packaged or predetermined amount. By reserving a PourMyBeer™ table, customers can guarantee favorite draft beers will be on tap for the night.
Oncolytics Biotech® Inc. Announces Initial US$1.0 Million Investment and Up to US$25.0 Million Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC
PR Newswire - Thu Feb 27, 8:26AM CST
Oncolytics Biotech Inc. ("Oncolytics" or the "Company" (TSX:ONC; NASDAQ:ONCY) announced today that it has entered into a share purchase agreement (the "Purchase Agreement" with Lincoln Park Capital Fund, LLC ("LPC" that will provide an initial investment in Oncolytics of US$1.0 million and make available additional periodic investments of up to US$25.0 million over a 30-month term (the "Financing" .
Facebook CEO says WhatsAPP Worth More than $19B; Lincoln Park Capital Invests in Nuvilex
ACCESSWIRE - Tue Feb 25, 3:48AM CST
Verizon Communications Inc. (NYSE: VZ) - For an in-depth report on Verizon Communications Inc. follow: www.BullTrends.com/stockquote/VZ
Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex Unseat Celgene and Eli Lilly
Marketwire - Mon Feb 24, 8:04AM CST
Lincoln Park Capital (LPC) purchased 8 million restricted shares of Nuvilex, Inc. (OTCQB: NVLX) in exchange for an initial $2 million out of what can be viewed as a $27 million "pot of money" to advance the company's late-phase pancreatic cancer clinical trials. Notice we said restricted shares, that's right, LPC has put a great deal of its money on the line with a number of built in protections for Nuvilex. But, is this investment really a risk? It appears the Chicago-based firm knows exactly what the future could hold for Nuvilex, and they're comfortable with paying a premium price to become a long-term investor right along with many others who believe in the small biotechnology firm.
HPEV, Inc. Enters Into $10 Million Stock Purchase Agreement With Lincoln Park Capital Fund, LLC
Marketwire - Mon Feb 24, 5:21AM CST
HPEV, Inc. (OTCQB: WARM), an innovator in energy efficiency and heat dispersion technologies, announced today that it has entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC" , a Chicago-based institutional investor, whereby LPC committed to invest, at the HPEV's sole option, up to $10 million of equity capital pursuant to the purchase agreement. Drexel Hamilton LLC acted as the exclusive placement agent on behalf of the Company for the transaction.
Nuvilex Announces $27 Million Funding Commitment With Institutional Investor to Advance Late Phase Clinical Trials
GlobeNewswire - Thu Feb 20, 8:00AM CST
Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, announced today that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC (Lincoln Park), a Chicago-based institutional investor. Lincoln Park initially purchased 8 million shares of Nuvilex's common stock at $0.25 per share for $2 million and has committed to invest, at the sole option of Nuvilex, up to an additional $25 million of equity capital over the term of the purchase agreement. The proceeds from this investment will be used for Nuvilex's late-stage clinical trials in advanced inoperable pancreatic cancer, for research into the use of constituents of marijuana in the emerging medical marijuana arena and for general operating purposes.
Artisanal Grocery Online Store Artizone.com Partners With WeDeliver For Delivery Efficacy
PR Newswire - Tue Feb 11, 4:00PM CST
Artizone.com, Chicagoland's only online and year-round marketplace for fresh, small-batch, high-quality foods is partnering with on-demand local delivery service WeDeliver to help increase delivery and product availability from some of Artizone's popular artisan partners.
KonaRed Corp Analyst Report issued by BrokerBank Securities, Inc.
PR Newswire - Tue Feb 11, 6:00AM CST
KonaRed Corp (OTCQB: KRED) brings the health and wellness properties of the coffee fruit (the shell that surrounds the coffee bean) to the market. KonaRed has developed an innovative, process that produces antioxidant-packed extracts and powders from the coffee fruit which are used in its antioxidant juices, organic green teas, and on-the-go packs, as well as ingredients which can be added to food, beverages, and nutritional products.
Plandai Biotechnology, Inc. Completes $15.3 Million Funding Commitment With Institutional Investor
Marketwire - Mon Feb 10, 8:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor, whereby Lincoln Park committed to invest, at the Company's sole option, up to $15.3 million of equity capital over the term of the purchase agreement including an initial investment of $300,000.
Lincoln Park Bancorp Announces Earnings For The Quarter Ended June 30, 2014
PR Newswire - Fri Aug 08, 4:00PM CDT
Lincoln Park Bancorp (OTC Bulletin Board: LPBC) (the "Company"
, the holding company of Lincoln Park Savings Bank, announced net income of $327,000, or $.19 per share, for the quarter ended June 30, 2014, compared to net income of $216,000 or $.12 per share, for the quarter ended June 30, 2013. The increase in net income of $111,000 was primarily due to an increase in net interest income after provision for loan losses, partially offset by a decrease in non-interest income, an increase in non-interest expenses, and an increase in income tax expense. Poll Shows Americans Deeply Concerned about Online Privacy, Mistrust Social Media
PR Newswire - Thu Jul 31, 7:30AM CDT
Almost three-quarters of Americans worry about the quantity of personal information available online and more than half feel they cannot trust social media sites like Facebook and Twitter to keep their contact information, buying habits and political beliefs confidential, according to new poll data released today at http://www.onlineprivacydata.org.
Biodel signs USD15m equity agreement with Lincoln Park Capital
M2 - Mon Jul 28, 6:24AM CDT
Biopharmaceutical company Biodel (NasdaqCM:BIOD) revealed on Monday the execution of a USD15m stock purchase agreement with Lincoln Park Capital Fund (LPC), a Chicago-based institutional investor.
Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital
Marketwire - Mon Jul 28, 5:00AM CDT
Biodel Inc. (NASDAQ: BIOD) today announced that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"
, a Chicago-based institutional investor. Under the terms of the purchase agreement, Biodel will have the right to sell to LPC, and LPC will be obligated to purchase, up to $15 million in shares of Biodel's common stock, subject to the limitations and conditions set forth in the agreement. Biodel intends to use any proceeds that it receives from the sale of shares under the purchase agreement for general corporate purposes and working capital requirements. Miller-Valentine Group Proudly Announces the 25th Anniversary of Lincoln Park Manor in Kettering, Ohio
PRWeb - Wed Jul 16, 1:36PM CDT
This year marks the 25th anniversary of Lincoln Park Manor as their first patient was admitted on July 17, 1989. Lincoln Park Manor is owned by Miller-Valentine Group, a trusted name in Dayton and many communities. Together they have built a reputation of integrity and best business practices. Every day the staff at Lincoln Park Manor lives up to these expectations and strives to exceed them. Their dedication has been acknowledged by achieving a deficiency free health survey for the last two consecutive annual surveys conducted by the Ohio Department of Health and a 5 Star Rating with Medicare.
Advanced Cell Technology Secures $30 Million Equity Facility from Lincoln Park Capital
Business Wire - Thu Jul 03, 8:05AM CDT
Advanced Cell Technology, Inc. ("ACT"
(OTCBB:ACTC), a leader in the field of regenerative medicine, today announced that it has entered into a $30 million common stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC" . Amarantus BioScience Holdings, Inc. "Transformational Funding Positions Amarantus Heading into 2014 Milestones"
ACCESSWIRE - Mon Mar 10, 12:46PM CDT
New York, NY / ACCESSWIRE / March 10, 2014 / Amarantus BioScience Holdings, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman's Blog, written by the Company's CEO, Mr. Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC
GlobeNewswire - Mon Mar 10, 5:00AM CDT
Amarantus Bioscience Holdings, Inc. (OTC:AMBS) (Amarantus or the Company), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, announced today that it has closed on its previously announced Warrant Solicitation, which the Company elected to increase in size from $3.0M to $3.6M due to oversubscriptions. Concurrently, the Company entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"
, a Chicago-based institutional investor. LPC initially purchased 4.0 million shares of Amarantus' common stock at $0.10 per share for $400,000 and has committed to invest, at the sole option of Amarantus, up to an additional $19.6M of equity capital over the term of the purchase agreement. The total gross proceeds to the Company from these two transactions upon closing is $4M. Experience the Difference at Lincoln Park Manor; Recognized for Deficiency-Free Health Survey
PRWeb - Sat Mar 08, 11:45AM CST
Russ Holtz, Executive Director of Lincoln Mark Manor, is proud of the 2014 survey results and is honored with the overall 5-Star rating from Medicare. Holtz states, "We have maintained this outstanding accomplishment for the second consecutive year. We understand the importance of having an amazing, caring team of staff members who continue to play a key role towards this distinction year after year."
PourMyBeer™ Revolutionizes Beer Service in Chicago with Introduction of Self-Serve System
PRWeb - Fri Mar 07, 5:05AM CST
Craft beer is at an all-time high and customer demand for beer means the need to serve them more quickly, efficiently and responsibly is greater than ever. Enter the PourMyBeer™ system. It conveniently allows customers to purchase and pour their own beer, with staff interaction and oversight of course. It also allows customers to pay only for what they drink, instead of a packaged or predetermined amount. By reserving a PourMyBeer™ table, customers can guarantee favorite draft beers will be on tap for the night.
Oncolytics Biotech® Inc. Announces Initial US$1.0 Million Investment and Up to US$25.0 Million Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC
PR Newswire - Thu Feb 27, 8:26AM CST
Oncolytics Biotech Inc. ("Oncolytics" or the "Company"
(TSX:ONC; NASDAQ:ONCY) announced today that it has entered into a share purchase agreement (the "Purchase Agreement" with Lincoln Park Capital Fund, LLC ("LPC" that will provide an initial investment in Oncolytics of US$1.0 million and make available additional periodic investments of up to US$25.0 million over a 30-month term (the "Financing" . Facebook CEO says WhatsAPP Worth More than $19B; Lincoln Park Capital Invests in Nuvilex
ACCESSWIRE - Tue Feb 25, 3:48AM CST
Verizon Communications Inc. (NYSE: VZ) - For an in-depth report on Verizon Communications Inc. follow: www.BullTrends.com/stockquote/VZ
Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex Unseat Celgene and Eli Lilly
Marketwire - Mon Feb 24, 8:04AM CST
Lincoln Park Capital (LPC) purchased 8 million restricted shares of Nuvilex, Inc. (OTCQB: NVLX) in exchange for an initial $2 million out of what can be viewed as a $27 million "pot of money" to advance the company's late-phase pancreatic cancer clinical trials. Notice we said restricted shares, that's right, LPC has put a great deal of its money on the line with a number of built in protections for Nuvilex. But, is this investment really a risk? It appears the Chicago-based firm knows exactly what the future could hold for Nuvilex, and they're comfortable with paying a premium price to become a long-term investor right along with many others who believe in the small biotechnology firm.
HPEV, Inc. Enters Into $10 Million Stock Purchase Agreement With Lincoln Park Capital Fund, LLC
Marketwire - Mon Feb 24, 5:21AM CST
HPEV, Inc. (OTCQB: WARM), an innovator in energy efficiency and heat dispersion technologies, announced today that it has entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"
, a Chicago-based institutional investor, whereby LPC committed to invest, at the HPEV's sole option, up to $10 million of equity capital pursuant to the purchase agreement. Drexel Hamilton LLC acted as the exclusive placement agent on behalf of the Company for the transaction. Nuvilex Announces $27 Million Funding Commitment With Institutional Investor to Advance Late Phase Clinical Trials
GlobeNewswire - Thu Feb 20, 8:00AM CST
Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, announced today that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC (Lincoln Park), a Chicago-based institutional investor. Lincoln Park initially purchased 8 million shares of Nuvilex's common stock at $0.25 per share for $2 million and has committed to invest, at the sole option of Nuvilex, up to an additional $25 million of equity capital over the term of the purchase agreement. The proceeds from this investment will be used for Nuvilex's late-stage clinical trials in advanced inoperable pancreatic cancer, for research into the use of constituents of marijuana in the emerging medical marijuana arena and for general operating purposes.
Artisanal Grocery Online Store Artizone.com Partners With WeDeliver For Delivery Efficacy
PR Newswire - Tue Feb 11, 4:00PM CST
Artizone.com, Chicagoland's only online and year-round marketplace for fresh, small-batch, high-quality foods is partnering with on-demand local delivery service WeDeliver to help increase delivery and product availability from some of Artizone's popular artisan partners.
KonaRed Corp Analyst Report issued by BrokerBank Securities, Inc.
PR Newswire - Tue Feb 11, 6:00AM CST
KonaRed Corp (OTCQB: KRED) brings the health and wellness properties of the coffee fruit (the shell that surrounds the coffee bean) to the market. KonaRed has developed an innovative, process that produces antioxidant-packed extracts and powders from the coffee fruit which are used in its antioxidant juices, organic green teas, and on-the-go packs, as well as ingredients which can be added to food, beverages, and nutritional products.
Plandai Biotechnology, Inc. Completes $15.3 Million Funding Commitment With Institutional Investor
Marketwire - Mon Feb 10, 8:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor, whereby Lincoln Park committed to invest, at the Company's sole option, up to $15.3 million of equity capital over the term of the purchase agreement including an initial investment of $300,000.
